US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Carb-O-Philic 40 Cream

Reason CGMP Deviation: Poor container closure of the bulk storage container

Geritrex Corp NDC 54162-640-03 D-1238-2015
Class III · Low risk Terminated

Dr Blue Pain Relieving Gel

Reason Superpotent Drug: Product may not be uniformly blended resulting in non-uniform distribution of the active ingredient menthol.

Indiana Botanic Gardens, Inc NDC 10578-035-05 D-1149-2015
Class III · Low risk Terminated

Lutera

Reason Labeling: Incorrect or Missing Package Insert; Product is being recalled because the birth control packs were distributed with out-dated package inserts.

Actavis Inc NDC 52544-0949-28 D-1148-2015
Class III · Low risk Terminated

E-Z-CAT Dry Barium Sulfate for Suspension

Reason Failed stability specifications:This recall has been initiated due to out of specification results for viscosity.

Bracco Diagnostic Inc NDC 32909-727-01 D-1147-2015
Class III · Low risk Terminated

Foradil Aerolizer

Reason Failed Stability Specification: out of specification result obtained for the Particle Size Distribution test during stability testing.

Novartis Pharmaceuticals Corp. D-1138-2015
Class III · Low risk Terminated

Foradil Aerolizer

Reason Failed Stability Specification: out of specification result obtained for the Particle Size Distribution test during stability testing.

Novartis Pharmaceuticals Corp. D-1137-2015
Class III · Low risk Terminated

Magnesium Sulfate Injection

Reason Failed pH Specifications: 12 month stability testing

Hospira Inc. NDC 0409-2168-02 D-1232-2015
Class III · Low risk Terminated

Fentanyl Citrate Inj.

Reason Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548).

West-Ward Pharmaceutical Corp. NDC 0641-6028-25 D-1139-2015
Class III · Low risk Terminated

Qvar

Reason Failed Impurities/Degradation Specifications: out of specification test results for an impurity during stability testing.

Teva Pharmaceuticals USA NDC 59310-0202-12 D-1087-2015
Class III · Low risk Terminated

Levalbuterol Inhalation Solution

Reason Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.

Cipla Limited D-1078-2015
Class III · Low risk Terminated

Ic-Green

Reason Subpotent Drug: Low out-of-specification potency result of the drug product.

Akorn, Inc. NDC 17478-701-02 D-1429-2015
Class III · Low risk Terminated

Librax

Reason Failed Impurities/Degradation Specifications

Valeant Pharmaceuticals North America LLC NDC 0187-4100-10 D-1034-2016
Class III · Low risk Terminated

Cetirizine HCl Chewable Tablet

Reason Failed Impurities/Degradation Specifications: An out of specification (OOS) result was reported for impurity at the 21 month stability time point.

Sandoz, Inc NDC 66394-041-06 D-1115-2015
Class III · Low risk Terminated

Flurandrenolide Tape

Reason Subpotent Drug: Flurandrenolide is subpotent.

Actavis Laboratories D-0486-2015
Class III · Low risk Terminated

Monistat 1 Simple Cure

Reason Marketed without an approved NDA/ANDA: The distributed units of Monistat 1 Simple Cure include only the 1200 mg vaginal suppository; the approved NDA requires both a 1200 mg vaginal suppository and the 2% topical cream.

Medtech Products, Inc. NDC 63736-013-30 D-1077-2015
Class III · Low risk Terminated

Olanzapine

Reason Subpotent drug

Apotex Inc. D-1081-2015
Class III · Low risk Terminated

Olanzapine

Reason Subpotent drug

Apotex Inc. NDC 60505-3276-03 D-1080-2015
Class III · Low risk Terminated

Olanzapine

Reason Subpotent drug

Apotex Inc. NDC 60505-3275-03 D-1079-2015